Serenity Treatment Center of Louisiana
2325 Weymouth Drive, Baton Rouge, LA 70809
Serenity Treatment Center of Louisiana is an intensive outpatient, outpatient, and residential facility in Baton Rouge, LA offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, TRICARE, Medicaid, and private insurance.
Licenses and accreditations
- Commission on Accreditation of Rehabilitation Facilities (CARF)Accredited by CARF, an independent nonprofit accreditor of health and human services.
- State department of healthLicensed by the state's department of health.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Intensive outpatient treatment
- Several hours of treatment a day, several days a week, while living at home.
- Outpatient
- Regular appointments while living at home.
- Regular outpatient treatment
- Weekly or less frequent appointments while living at home.
- Residential/24-hour residential
- Living at the facility during treatment.
- Short-term residential
- Living at the facility for 30 days or less.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Lofexidine or Clonidine detoxification
- Lofexidine or clonidine to ease withdrawal during detox.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
Payment
- Accepted
- Cash or self-payment; TRICARE and other federal military insurance; Indian Health Service, tribal, or urban Indian health funds; Medicaid; Private health insurance.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Languages
- Sign language services for the deaf and hard of hearing.
More details this facility reports
- Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- Other contracted prescribing entity.
- Pharmacotherapies
- Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Medication for mental disorders; Medications for HIV treatment; Medications for Hepatitis C treatment; Medications for pre-exposure to prophylaxis; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement.
- Treatment Approaches
- 12-step facilitation; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling.
- Facility Operation (e.g., Private, Public)
- Private for-profit organization.
- Assessment/Pre-treatment
- Complete medical history/physical exam; Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
- Testing
- Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring; STD testing; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV).
- Transitional Services
- Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
- Recovery Support Services
- Assistance with obtaining social services; Housing services; Mentoring/peer support; Self-help groups.
- Education and Counseling Services
- Family counseling; Group counseling; Individual counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping permitted in designated area.
- Ancillary Services
- Case management service; Transportation assistance.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.